Francesco Maisano joins Lars Sondergaard for a short but rich exchange of views on the TRILUMINATE Pivotal trial while #EuroPCR 2023 is in full swing.

This randomized trial, comparing TriClip versus medical treatment, was the first of its kind, and its initial outcomes are already very interesting, and positive, mainly because of improvement of quality of life.

To find out more about the results of this trial and its impact on patients, watch this short video interview!

Sponsored by Abbott

More videos on: [ Ссылка ]

#tricuspidvalve
#tricuspidregurgitation

свернуть